Cytek Biosciences (CTKB) Free Cash Flow (QoQ) (2020 - 2026)
Cytek Biosciences (CTKB) Free Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn |
| 10 | Cytek Biosciences | 562.44 Mn | 496.74 Mn | 21.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -324.64% |
| Dec 31, 2025 | 131.45% |
| Sep 30, 2025 | -2,398.34% |
| Jun 30, 2025 | 184.12% |
| Mar 31, 2025 | -118.71% |
| Dec 31, 2024 | -86.98% |
| Sep 30, 2024 | 186.20% |
| Jun 30, 2024 | 51.95% |
| Mar 31, 2024 | -73.14% |
| Dec 31, 2023 | 271.54% |
| Sep 30, 2023 | -168.41% |
| Jun 30, 2023 | -200.81% |
| Mar 31, 2023 | 906.82% |
| Dec 31, 2022 | 96.09% |
| Sep 30, 2022 | 23.90% |
| Jun 30, 2022 | -562.76% |
| Mar 31, 2022 | -141.14% |
| Dec 31, 2021 | 364.63% |
| Sep 30, 2021 | 58.08% |
| Jun 30, 2021 | -362.48% |